Lung Disease News and Research

RSS

The debilitating effects of long-COVID in the U.S.

A new study posted to the preprint server medRxiv* discusses chronic disability due to long COVID in the United States.

14 Dec 2022

Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection

Researchers compared the efficiency of bioengineered soluble ACE-2 concerning brain protection during COVID-19.

12 Dec 2022

New spatial cell atlas of the developing human lung identifies 144 cell states

The developing human lung has been mapped in unprecedented detail, identifying 144 cell states in the early stages of life, and uncovering new links between developmental cells and lung cancer.

8 Dec 2022

T-DXd leads to longer overall survival in HER2-positive metastatic breast cancer patients than T-DM1

Second-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer, according to updated results from the DESTINY-Breast03 phase III clinical trial presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

7 Dec 2022

T-DXd shows high efficacy in HER2-positive breast cancer patients previously treated with T-DM1

Compared with capecitabine-based regimens, trastuzumab deruxtecan (T-DXd) led to higher response rates and longer survival in the third-line setting for patients with HER2-positive metastatic breast cancer previously treated with trastuzumab emtansine (T-DM1), according to results from the phase III DESTINY-Breast02 trial presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

7 Dec 2022

Study reports overall response of HER2-low breast cancer patients to neoadjuvant T-DXd treatment

Patients with localized, hormone receptor-positive, HER2-low breast cancer treated with trastuzumab deruxtecan (T-DXd, Enhertu) in the neoadjuvant setting had an overall response rate of 75 percent in the absence of anastrozole and 63 percent in combination with anastrozole, according to results from the phase II TRIO-US B-12 TALENT trial presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

7 Dec 2022

What is the prevalence of pulmonary tissue injury among hospitalized COVID-19 patients?

Researchers identified risk factors for and the prevalence of persistent pulmonary tissue alterations among hospitalized coronavirus disease 2019 (COVID-19) patients.

7 Dec 2022

Study assesses the prevalence of residual lung abnormalities following COVID-19 hospitalization

In a new study published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine, researchers sought to determine the percentage of COVID-19 patients discharged from the hospital who had a type of fibrotic lung damage, known as interstitial lung disease, that requires ongoing follow-up care.

2 Dec 2022

Photon-counting CT may help to effectively identify post-COVID patients at risk for lung damage

New CT technology outperforms conventional CT in detecting subtle damage in the lungs of patients with persistent symptoms of COVID-19, according to a new study published in Radiology, a journal of the Radiological Society of North America.

29 Nov 2022

Should older seniors risk major surgery? New research offers guidance

Nearly 1 in 7 older adults die within a year of undergoing major surgery, according to an important new study that sheds much-needed light on the risks seniors face when having invasive procedures.

28 Nov 2022

Study shows link between vaping and risk of caries

A vaping habit could end up leading to a tarnished smile, and more frequent visits to the dentist.

23 Nov 2022

OSU researchers develop novel nanomedicine technique for diagnosing and ending ectopic pregnancies

Oregon State University scientists have produced a proof of concept for a new and better way of caring for women facing the life-threatening situation of ectopic pregnancy, which occurs when a fertilized egg implants somewhere other than the lining of the uterus.

22 Nov 2022

Low-dose CT screening improves survival rate of lung cancer patients

Diagnosing early-stage lung cancer with low-dose computed tomography (CT) screening drastically improves the survival rate of cancer patients over a 20-year period, according to a large-scale international study being presented by Mount Sinai researchers at the annual meeting of the Radiological Society of North America.

22 Nov 2022

Study identifies risk factors and symptom clusters associated with long-COVID

A recent study posted to medRxiv* preprint server evaluated risk factors associated with long COVID.

17 Nov 2022

Emphysema rates higher among marijuana smokers than cigarette smokers

Airway inflammation and emphysema are more common in marijuana smokers than cigarette smokers, according to a study published in Radiology, a journal of the Radiological Society of North America.

15 Nov 2022

One in four people with COPD waited more than five years for a diagnosis, research reveals

Asthma + Lung UK is calling for lung health to become an urgent priority after a damning report, released ahead of World COPD Day tomorrow, reveals that almost a quarter1 of people surveyed with the deadly lung disease chronic obstructive pulmonary disease (COPD), waited more than five years for a diagnosis, whilst one in eight waited more than a decade.

15 Nov 2022

Flu cases continue to rise throughout the U.S.

The rate of influenza cases throughout the U.S. continues to rise.

13 Nov 2022

World Pneumonia Day 2022: Pneumonia Affects Everyone

In commemoration of World Pneumonia Day 2022, we speak to Dr. Andy Whittamore, GP and Clinical Lead at Asthma + Lung UK, about the effect pneumonia can have on everyone.

13 Nov 2022

What is the role of adenoviruses in human health?

With advances in molecular biology informing recent developments in vaccinology, gene therapy, and other fields of medicine, human adenoviruses (HAdVs) have been of primary importance in medical research. A recent review looks at the promises of HAdVs, their potential dangers, and future challenges.

9 Nov 2022

Paxlovid antiviral therapy reduces risk of long COVID

In a recent study posted to the medRxiv* server, researchers in Saint Louis, Missouri, examined whether nirmatrelvir treatment reduced the risk of long COVID, the disease encompassing the post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [PASC].

7 Nov 2022

Lung Disease News and Research

The debilitating effects of long-COVID in the U.S.

Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection

New spatial cell atlas of the developing human lung identifies 144 cell states

T-DXd leads to longer overall survival in HER2-positive metastatic breast cancer patients than T-DM1

T-DXd shows high efficacy in HER2-positive breast cancer patients previously treated with T-DM1

Study reports overall response of HER2-low breast cancer patients to neoadjuvant T-DXd treatment

What is the prevalence of pulmonary tissue injury among hospitalized COVID-19 patients?

Study assesses the prevalence of residual lung abnormalities following COVID-19 hospitalization

Photon-counting CT may help to effectively identify post-COVID patients at risk for lung damage

Should older seniors risk major surgery? New research offers guidance

Study shows link between vaping and risk of caries

OSU researchers develop novel nanomedicine technique for diagnosing and ending ectopic pregnancies

Low-dose CT screening improves survival rate of lung cancer patients

Study identifies risk factors and symptom clusters associated with long-COVID

Emphysema rates higher among marijuana smokers than cigarette smokers

One in four people with COPD waited more than five years for a diagnosis, research reveals

Flu cases continue to rise throughout the U.S.

World Pneumonia Day 2022: Pneumonia Affects Everyone

What is the role of adenoviruses in human health?

Paxlovid antiviral therapy reduces risk of long COVID

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News